Crescent Biopharma, Inc. (CBIO): Shares Outstanding

Annual figures by period end, from SEC filings.

27.56M
As of 2025-12-31
27.76M
As of 2026-06-30
-20.3%
3-year compound annual growth
-10.9%
5-year compound annual growth
64.39M2013-12-31: 1.43M2014-12-31: 18.94M2015-12-31: 19.05M2016-12-31: 23.25M2017-12-31: 34.36M2018-12-31: 43.16M2019-12-31: 43.47M2020-12-31: 49.02M2021-12-31: 52.31M2022-12-31: 54.38M2023-12-31: 64.39M2024-12-31: 1.02M2025-12-31: 27.56M27.56M
2013-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3127.56Mn/m2026-02-26, Balance as of period end
2024-12-311.02M-98.4%2026-02-26, Balance as of period end
2023-12-3164.39M+18.4%2025-02-13, Balance as of period end
2022-12-3154.38M+3.9%2024-03-27, Balance as of period end
2021-12-3152.31M+6.7%2023-03-29, Balance as of period end
2020-12-3149.02M+12.8%2022-03-03, Balance as of period end
2019-12-3143.47M+0.7%2021-03-02, Balance as of period end
2018-12-3143.16M+25.6%2020-02-28, Balance as of period end
2017-12-3134.36Mn/c2019-03-06, Balance as of period end
2016-12-3123.25M+22.0%2018-03-06, Balance as of period end
2015-12-3119.05M+0.6%2017-03-01, Balance as of period end
2014-12-3118.94Mn/m2016-02-29, Balance as of period end
2013-12-311.43Mn/a2015-03-16, Balance as of period end